References
- Qureshi AI, Janardhan V. Mechanisms of ischemic brain injury. Curr Cardiol Rep. 2004;6(2):117–23. doi:https://doi.org/10.1007/s11886-004-0009-8.
- Maki T, Hayakawa K, Pham L-DD, Xing C, Lo EH, Arai K. Biphasic mechanisms of neurovascular unit injury and protection in CNS diseases. CNS Neurol Disord Drug Targets. 2013. doi:https://doi.org/10.2174/1871527311312030004.
- Lee RHC, Lee MHH, Wu CYC, et al. Cerebral ischemia and neuroregeneration. Neural Regen Res. 2018;13(3):373–85. doi:https://doi.org/10.4103/1673-5374.228711.
- Hypoxia modulates the barrier and coagulant function of cultured bovine endothelium. Increased monolayer permeability and induction of procoagulant properties. J Clin Invest. 1990;85(4):1090–8. doi:https://doi.org/10.1172/JCI114540.
- Benjamin EJ, Virani SS, Callaway CW, et al. Heart disease and stroke statistics – 2018 update: a report from the American Heart Association. Circulation. 2018. doi:https://doi.org/10.1161/CIR.0000000000000558.
- Feigin VL, Norrving B, Mensah GA. Global Burden of Stroke. Circ Res. 2017;120:439–48. doi:https://doi.org/10.1161/CIRCRESAHA.116.308413.
- Feigin VL, Krishnamurthi RV, Theadom AM, et al. Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol. 2017;16(11):877–97. doi:https://doi.org/10.1016/S1474-4422(17)30299-5.
- World Health Organization. World Health Statistics. 2016. https://www.who.int/features/factfiles/obesity/en/.
- Dhingra R, Sullivan L, Jacques PF, Wang TJ, Fox CS, Meigs JB, et al. Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community. Circulation. 2007;116(5):480–8. doi:https://doi.org/10.1161/CIRCULATIONAHA.107.689935.
- Kahn R, Sievenpiper JL. Dietary sugar and body weight: have we reached a crisis in the epidemic of obesity and diabetes? — we have but the pox on sugar is overwrought and overworked. Diabetes Care. 2014;37(4):957–62. doi:https://doi.org/10.2337/dc13-2506.
- Tappy L, Le K-A. Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev. 2010;90(1):23–46. doi:https://doi.org/10.1152/physrev.00019.2009.
- Vuilleumier S. Worldwide production of high-fructose syrup and crystalline fructose. Am J Clin Nutr. 1993. doi: https://doi.org/10.1093/ajcn/58.5.733S
- Bray GA, Nielsen SJ, Popkin BM. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr. 2004.
- Duffey KJ, Popkin BM. Shifts in patterns and consumption of beverages between 1965 and 2002. Obesity. 2007. doi: https://doi.org/10.1038/oby.2007.326
- Lustig RH. Fructose: metabolic, hedonic, and societal parallels with ethanol. J Am Diet Assoc. 2010;110(9):1307–21. doi:https://doi.org/10.1016/j.jada.2010.06.008.
- Lyssiotis CA, Cantley LC. Metabolic syndrome: F stands for fructose and fat. Nature. 2013;502(7470):181–2. doi:https://doi.org/10.1038/502181a.
- Osmond JM, Mintz JD, Dalton B, Stepp DW. Vascular remodeling, and severity of stroke in the. Vascular. 2010;53(2):381–6. doi:https://doi.org/10.1161/HYPERTENSIONAHA.108.124149.OBESITY.
- Deutsch C, Portik-Dobos V, Smith AD, Ergul A, Dorrance AM. Diet-induced obesity causes cerebral vessel remodeling and increases the damage caused by ischemic stroke. Microvasc Res. 2009;78(1):100–6. doi:https://doi.org/10.1016/j.mvr.2009.04.004.
- Terao S, Yilmaz G, Stokes KY, Ishikawa M. Inflammatory and injury responses to ischemic stroke in obese mice. Stroke. 2008. doi:https://doi.org/10.1161/STROKEAHA.107.494542.
- Haley MJ, Lawrence CB. Obesity and stroke: can we translate from rodents to patients? J Cereb Blood Flow Metab. 2016. doi:https://doi.org/10.1177/0271678X16670411.
- Marosi M, Rákos G, Robotka H, Németh H, Sas K, Kis Z, et al. Hippocampal (CA1) activities in Wistar rats from different vendors. Fundamental differences in acute ischemia. J Neurosci Methods. 2006. doi: https://doi.org/10.1016/j.jneumeth.2006.03.010
- Garcia JH, Wagner S, Liu KF, Hu XJ. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke. 1995. doi: https://doi.org/10.1161/01.STR.26.4.627
- Guillemot-legris O, Muccioli GG. Obesity-induced neuroinflammation: beyond the hypothalamus. Trends Neurosci. 2017;40(4):237–53. doi:https://doi.org/10.1016/j.tins.2017.02.005.
- Akram M, Hamid A. Mini review on fructose metabolism. Obes Res Clin Pract. 2013;7(2):e89–e94. doi:https://doi.org/10.1016/j.orcp.2012.11.002.
- Stanhope KL, Medici V, Bremer AA, Lee V, Lam HD, Nunez MV, et al. A dose-response study of consuming high-fructose corn syrup – sweetened beverages on lipid/lipoprotein risk factors for cardiovascular disease in young adults 1–6. Am J Clin Nutr. 2015;101:1144–54. doi:https://doi.org/10.3945/ajcn.114.100461.1144 doi: https://doi.org/10.3945/ajcn.114.100461
- de Castro UGM, dos Santos RAS, Silva ME, de Lima WG, Campagnole-Santos MJ, Alzamora AC. Age-dependent effect of high-fructose and high-fat diets on lipid metabolism and lipid accumulation in liver and kidney of rats. Lipids Health Dis. 2013;12(1):136. doi:https://doi.org/10.1186/1476-511X-12-136.
- Farin HMF, Abbasi F, Reaven GM. Body mass index and waist circumference correlate to the same degree with insulin-mediated glucose uptake. Metabolism. 2005;54(10):1323–8. doi:https://doi.org/10.1016/j.metabol.2005.04.021.
- Chen R, Ovbiagele B, Feng W. Diabetes and stroke: epidemiology, pathophysiology, pharmaceuticals and outcome. Am J Med Sci. 2017;351(4):380–6. doi:https://doi.org/10.1016/j.amjms.2016.01.011.Diabetes doi: https://doi.org/10.1016/j.amjms.2016.01.011
- Kim KA, Shin D, Kim JH, Shin YJ, Rajanikant GK, Majid A, et al. Role of autophagy in endothelial damage and blood–brain barrier disruption in ischemic stroke. Stroke. 2018. doi: https://doi.org/10.1161/STROKEAHA.117.017287
- Yoon JS, Jo D, Lee H-S, et al. Spatiotemporal protein Atlas of cell death-related molecules in the Rat MCAO stroke model. Exp Neurobiol. 2018;27(4):287. doi:https://doi.org/10.5607/en.2018.27.4.287.
- Yamashita K, Vogel P, Fritze K, Back T, Hossmann KA, Wiessner C. Monitoring the temporal and spatial activation pattern of astrocytes in focal cerebral ischemia using in situ hybridization of GFAP mRNA: comparison with sgp-2 and hsp70 mRNA and the effect of glutamate receptor antagonists. Brain Res. 1996;735(2):285–97. doi:https://doi.org/10.1016/0006-8993(96)00578-1.
- Liu D, Smith CL, Barone FC, Ellison JA, Lysko PG, Li K. Astrocytic demise precedes delayed neuronal death in focal ischemic rat brain. Mol Brain Res. 1999;68(1–2):29–41. doi:https://doi.org/10.1016/S0169-328X(99)00063-7.
- Posada-Duque RA, Barreto GE, Cardona-Gomez GP. Protection after stroke: cellular effectors of neurovascular unit integrity. Front Cell Neurosci. 2014;8:1–19. doi:https://doi.org/10.3389/fncel.2014.00231.
- Kanoski SE, Zhang Y, Zheng W, Davidson TL, Sciences H, Lafayette W. The effects of a high-energy diet on hippocampal function and blood-brain barrier integrity in the rat. J Alzheimer's Dis. 2010;21:207–19. doi:https://doi.org/10.3233/JAD-2010-091414.
- Van Dyken P, Lacoste B. Impact of metabolic syndrome on neuroinflammation and the blood–brain barrier. Front Neurosci. 2018;12. doi:https://doi.org/10.3389/fnins.2018.00930.
- Button EB, Mitchell AS, Domingos MM, et al. Microglial cell activation increases saturated and decreases monounsaturated fatty acid content, but both lipid species are proinflammatory. Lipids. 2014;49(4):305–16. doi:https://doi.org/10.1007/s11745-014-3882-y.
- Boutin H, LeFeuvre RA, Horai R, Asano M, Iwakura Y, Rothwell NJ. Role of IL-1alpha and IL-1beta in ischemic brain damage. J Neurosci. 2001;21(15):5528–34. doi: https://doi.org/10.1523/JNEUROSCI.21-15-05528.2001
- Wu X, Wu L, Zhang K, Hu G, Yan H, Xie C. Inflammatory response and neuronal necrosis in rats with cerebral ischemia. Neural Regen Res. 2014;9(19):1753). doi:https://doi.org/10.4103/1673-5374.143419.
- Krishnan SM, Sobey CG, Latz E, Mansell A, Drummond GR. IL-1β and IL-18: inflammatory markers or mediators of hypertension? Br J Pharmacol. 2014;171(24):5589–602. doi:https://doi.org/10.1111/bph.12876.
- Carmi Y, Voronov E, Dotan S, et al. The role of macrophage-derived IL-1 in induction and maintenance of angiogenesis. J Immunol. 2009;183(7):4705–14. doi:https://doi.org/10.4049/jimmunol.0901511.
- Calabrese F, Rossetti AC, Racagni G, Gass P, Riva MA, Molteni R. Brain-derived neurotrophic factor: a bridge between inflammation and neuroplasticity. Front Cell Neurosci. 2014. doi: https://doi.org/10.3389/fncel.2014.00430
- Sanchez-Mendoza EH, Hermann DM, Wang H, Caleo M, Bronfman F, Zeiler SR. Correlates of post-stroke brain plasticity, relationship to pathophysiological settings and implications for human proof-of-concept studies. Front Cell Neurosci. 2016. doi: https://doi.org/10.3389/fncel.2016.00196
- Schäbitz W-R, Steigleder T, Cooper-Kuhn CM, Schwab S, Sommer C, Schneide A, et al. Intravenous brain-derived neurotrophic factor enhances poststroke sensorimotor recovery and stimulates neurogenesis. Stroke. 2007;38(7):2165–72. doi:https://doi.org/10.1161/STROKEAHA.106.477331.
- Cai M, Wang H, Li J-J, Zhang YL, Xin L, Li F, et al. The signaling mechanisms of hippocampal endoplasmic reticulum stress affecting neuronal plasticity-related protein levels in high fat diet-induced obese rats and the regulation of aerobic exercise. Brain Behav Immun. 2016;57:347–59. doi:https://doi.org/10.1016/j.bbi.2016.05.010.
- Sarah MK, Wolf F, Ingo CM, Dominik B. Up-regulation of neurofilament light chains is associated with diminished immunoreactivities for MAP2 and tau after ischemic stroke in rodents and in a human case. J Chem Neuroanat. 2016. doi: https://doi.org/10.1016/j.jchemneu.2016.09.004
- Dawson DA, Hallenbeck JM. Acute focal ischemia-induced alterations in MAP2 immunostaining : description of temporal changes and utilization as a marker for volumetric assessment of acute brain injury. J Cereb Blood Flow Metab. 1996:16(1):170–4. doi: https://doi.org/10.1097/00004647-199601000-00020
- Lasagna-reeves CA, Castillo-carranza DL, Sengupta U, et al. Identification of oligomers at early stages of tau aggregation in Alzheimer’ s disease. FASEB J. 2012;26(5):1946–59. doi:https://doi.org/10.1096/fj.11-199851.
- Blair LJ, Frauen HD, Zhang B, Nordhues BA, Bijan S, Lin YC, et al. Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathy. Acta Neuropathol Commun. 2015;3:8. doi:https://doi.org/10.1186/s40478-015-0186-2.
- Laurent C, Buée L, Blum D. Tau and neuroinflammation: what impact for Alzheimer’s disease and tauopathies? Biomed J. 2018;41(1):21–33. doi:https://doi.org/10.1016/j.bj.2018.01.003.